| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |